NASDAQ: EDSA
Edesa Biotech Inc Stock Forecast, Predictions & Price Target

Analyst price target for EDSA

Based on 1 analyst offering 12 month price targets for Edesa Biotech Inc

Min Forecast
$21.00+919.42%
Avg Forecast
$21.00+919.42%
Max Forecast
$21.00+919.42%

Should I buy or sell EDSA stock?

Based on 1 analyst offering ratings for Edesa Biotech Inc.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their EDSA stock forecasts and price targets.

EDSA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-03-13

1 of 1

Forecast return on equity

Is EDSA forecast to generate an efficient return?

Company
N/A
Industry
141.47%
Market
90.4%

Forecast return on assets

Is EDSA forecast to generate an efficient return on assets?

Company
N/A
Industry
32.4%

EDSA earnings per share forecast

What is EDSA's earnings per share in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
-$1.40
Avg 2 year Forecast
-$0.56
Avg 3 year Forecast
-$0.45

EDSA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
EDSA$2.06$21.00+919.42%Buy
IBIO$0.87$5.50+529.29%Strong Buy
RLYB$0.35$5.00+1,320.45%Buy
MTVA$0.73$7.50+928.81%Strong Buy
SYBX$1.21N/AN/A

Edesa Biotech Stock Forecast FAQ

Is Edesa Biotech Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: EDSA) stock is to Buy EDSA stock.

Out of 1 analyst, 0 (0%) are recommending EDSA as a Strong Buy, 1 (100%) are recommending EDSA as a Buy, 0 (0%) are recommending EDSA as a Hold, 0 (0%) are recommending EDSA as a Sell, and 0 (0%) are recommending EDSA as a Strong Sell.

If you're new to stock investing, here's how to buy Edesa Biotech stock.

What is EDSA's earnings growth forecast for 2025-2027?

(NASDAQ: EDSA) Edesa Biotech's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 10.67%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.32%.

Edesa Biotech's earnings in 2025 is -$5,837,964.On average, 2 Wall Street analysts forecast EDSA's earnings for 2025 to be -$9,831,749, with the lowest EDSA earnings forecast at -$11,446,965, and the highest EDSA earnings forecast at -$8,216,533. On average, 1 Wall Street analyst forecast EDSA's earnings for 2026 to be -$3,932,700, with the lowest EDSA earnings forecast at -$3,932,700, and the highest EDSA earnings forecast at -$3,932,700.

In 2027, EDSA is forecast to generate -$3,160,205 in earnings, with the lowest earnings forecast at -$3,160,205 and the highest earnings forecast at -$3,160,205.

What is EDSA's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: EDSA) forecast ROE is N/A, which is considered weak.

What is EDSA's Price Target?

According to 1 Wall Street analyst that have issued a 1 year EDSA price target, the average EDSA price target is $21.00, with the highest EDSA stock price forecast at $21.00 and the lowest EDSA stock price forecast at $21.00.

The Wall Street analyst predicted that Edesa Biotech's share price could reach $21.00 by Mar 13, 2026. The average Edesa Biotech stock price prediction forecasts a potential upside of 919.42% from the current EDSA share price of $2.06.

What is EDSA's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: EDSA) Edesa Biotech's current Earnings Per Share (EPS) is -$1.59. On average, analysts forecast that EDSA's EPS will be -$1.40 for 2025, with the lowest EPS forecast at -$1.63, and the highest EPS forecast at -$1.17. On average, analysts forecast that EDSA's EPS will be -$0.56 for 2026, with the lowest EPS forecast at -$0.56, and the highest EPS forecast at -$0.56. In 2027, EDSA's EPS is forecast to hit -$0.45 (min: -$0.45, max: -$0.45).

What is EDSA's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: EDSA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 32.4%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.